| mRNA |
vorinostat:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
| mRNA |
darinaparsin |
CTRPv2 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.0035 |
0.9 |
| mRNA |
BMS-509744 |
GDSC1000 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |